The left bundle branch pacing-shock lead will become standard in implantable cardioverter-defibrillator therapy: pro

14 April 2026 (13:45 - 13:55)

Organised by:

Video

Sign in for access options

Slides

About the speaker

Doctor Jarkko Karvonen

Helsinki University Hospital, Helsinki (Finland)

5 More presentations in this session

Presentation thumbnail

Implantable cardioverter-defibrillator therapy is indicated in all patients with ischaemic cardiomyopathy and severe systolic dysfunction: pro

Professor C. Sticherling (Basel, CH)

Presentation thumbnail

Implantable cardioverter-defibrillator therapy is indicated in all patients with ischaemic cardiomyopathy and severe systolic dysfunction: con

Doctor N. Dagres (Berlin, DE)

Presentation thumbnail

Implantable cardioverter-defibrillator therapy is indicated in all patients with ischaemic cardiomyopathy and severe systolic dysfunction: discussion

Presentation thumbnail

The left bundle branch pacing-shock lead will become standard in implantable cardioverter-defibrillator therapy: con

Associate Professor G. Upadhyay (Chicago, US)

Presentation thumbnail

The left bundle branch pacing-shock lead will become standard in implantable cardioverter-defibrillator therapy: discussion

Access the full session

Session thumbnail

Debate on cardiac implantable electronic device therapy

The Event

Event poster

EHRA 2026

14 April 2026 13:45 CET

You may be interested in

Congress Session

Debate on cardiac implantable electronic device therapy

Congress Presentation

The left bundle branch pacing-shock lead will become standard in implantable cardioverter-defibrillator therapy: con

Congress Session

Debates and controversies in selection of cardiac implantable electronic devices

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources